期刊文献+

CD117阴性胃肠道间质瘤的临床病理及超微结构分析 被引量:2

Clinicopathological and ultrastructural analysis of gastrointestinal stromal tumours negative for CD117
下载PDF
导出
摘要 目的:探讨CD117阴性胃肠道间质瘤(gastrointestinal stromal tumours,GIST)的临床病理及超微结构特征.方法:采用HE、免疫组化(EnVision法)及电镜技术观察16例CD117阴性GIST,并运用Western blot技术检测4例GIST中PKC-θ蛋白的表达.结果:16例患者中男11例,女5例,年龄32~67柳岁,平均54岁.随访9例,死亡1例.组织学形态可分为梭形细胞为主型、上皮样细胞为主型及梭形和上皮样细胞混合型.肿瘤细胞免疫组化阳性表达为PKC-θ87.5%(14/16),CD117 0%(0/16),CD34 62.5%(10/16),Des 6.2%(1/16),θ-SMA 31.2%(5/16),S-100 18.8%(3/16).电镜下GIST的超微结构特点与卡哈尔细胞相似.Western blot证实了PKC-θ在CD117阴性GIST中的表达.结论:CD117阴性GIST可通过免疫标记PKC-θ和及电镜检测做出诊断. Objective:To investigate the clinicopathological and ultrastructural features of gastrointestinal stromal tumours (GIST) negative for CD117.Methods: Sixteen cases of GIST negative for CD117 were investigated with HE staining,EnVision immunostaining and electron microscopy.Western blot was used to test the expression of PKC-θ on 4 cases of GIST.Results:Eleven patients were male and five were female,32~67 years in age(average 54 years).Nine patients were followed up and one was dead.GIST tended to fall into three categories of morphology: spindle,epithelioid and mixed cell.Immunohistochemically,the tumours were positive for PKC-θ 88%(14/16),CD117 0%(0/16),CD34 63%(10/16),Des 6%(1/16),θ-SMA 31%(5/16) and S-100 19%(3/16) respectively.The ultrastructural feature of one case was similar to that of the interstitial cell of Cajal(ICC).Western blot confirmed the expression of PKC-θ on GIST negative for CD117.Conclusion:GIST negative for CD117 could be diagnosed by immunohistochemistry for PKC-θ and ultrastructural findings.
作者 姚婵 施公胜
出处 《南通大学学报(医学版)》 2009年第3期169-171,175,共4页 Journal of Nantong University(Medical sciences)
关键词 胃肠道间质瘤 CD117 蛋白激酶C-θ 超微结构 Gastrointestinal stromal tumours CD117 Protein kinase C-θ Ultrastructure
  • 相关文献

参考文献11

  • 1[1]Schubert ML,Moghimi R.Gastrointestinal stromal tumor (GIST)[J].Curr Treat Options Gastroenterol,2006,9 (2):181-188.
  • 2[2]DeMatteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival[J].Ann Surg,2000,231 (1):51-58.
  • 3[3]Miettinen M,Makhlouf H,Sobin LH,et al.Gastrointestinal stromal tumors of the jejunum and ileum:a clinicopathologic,immunohistochemical,and molecular genetic study of 906 cases before imatinib with long-term follow-up[J].Am J Surg Pathol,2006,30(4):477-489.
  • 4[4]Streutker CJ,Huizinga JD,Driman DK,et al.Interstitial cells of Cajal in health and disease.Part Ⅱ:ICC and gastrointestinal stromal tumors[J].Histopathology,2007,50(2):190-202.
  • 5[5]Heinrich MC,Corless CL,Demetri GD,et al.Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor[J].J Clin Oncol,2003,21(23):4342-4349.
  • 6[6]Rubin BP.Heinrich MC,Corless CL.Gastrointestinal stromal tumor[J].Lancet,2007,369(9574):1731-1741.
  • 7[7]Nielsen TO,West RB,Linn SC,et al.Molecular characterisation of soft tissue tumours:a gene expression stud y[J].Lancet,2002,359(9314):1301-1307.
  • 8[8]Blay P,Astudillo A,Buesa JM.et al.Protien kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias[J].Clin Cancer Res,2004,10(12 Pt1):4089-4095.
  • 9[9]Min KW,Sook Seo I.Interstitial cells of Cajal in the human small intestine:immunochemical and ultrastructural study[J].Ultrastruct Pathol,2003,27(2):67-78.
  • 10[10]Streutker CJ,Huizinga JD,Driman DK,et al.Interstitial cells of Cajal in health and disease.Part Ⅱ:ICC and gastrointestinal stromal tumours[J].Histopathology,2007,50(2):190-202.

同被引文献37

  • 1曹鹏,朱正龙,张伟.胃肠道间质肿瘤38例临床病理分析[J].南通大学学报(医学版),2007,27(2):111-112. 被引量:2
  • 2Schubert ML, R Moghimi. Gastrointestinal stromal tumor (GIST)[J]. Curr Treat Options Gastroenterol, 2006, 9(2) : 181-188.
  • 3Miettinen M,J Lasota. Gastrointestinal stromal tumors: pathologyand prognosis at different sites[ J]. Semin Diagn Pathol,2006,23(2): 70 -83.
  • 4Tomillo L,LM Terracciano. An update on molecular genetics ofgastrointestinal stromal tumours[ J]. J Clin Pathol, 2006,59(6):557 -563.
  • 5Lasota J, M Miettinen. Clinical significance of oncogenic KIT andPDGFRA mutations in gastrointestinal stromal tumours[ J]. Histo-pathology, 2008’ 53(3) : 245 -266.
  • 6Lasota J. KIT codon 558 insertions in gastrointestinal stromaltumors. Analysis of 17 rare KIT mutants[ J]. Hum Pathol,2008,39(12) : 1728 -1736.
  • 7Lasota J. Clinicopathologic profile of gastrointestinal stromal tumors(GISTs) with primary KIT exon 13 or exon 17 mutations : a multi-center study on 54 cases[J]. Mod Pathol,2008,21 (4) :476 -484.
  • 8Patil DT,BP Rubin. Gastrointestinal stromal tumor: Advances indiagnosis and management[ J]. Arch Pathol Lab Med, 2011,135(10) : 1298 -1310.
  • 9Fassunke J. qPCR in gastrointestinal stromal tumors: Evaluation ofreference genes and expression analysis of KIT and the alternativereceptor tyrosine kinases FLT3,CSF1 - R, PDGFRB, MET andAXL[J]. BMC Mol Biol, 2010,11: 100.
  • 10Wozniak A. Prognostic value of KIT/PDGFRA mutations in gastro-intestinal stromal tumours ( GIST) : Polish Clinical GIST Registryexperience[ J]. Ann Oncol, 2012, 23(2) : 353 -360.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部